Patents by Inventor Dinara GUNASEKERA

Dinara GUNASEKERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
    Patent number: 11813272
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: November 14, 2023
    Assignee: Flagship Pioneering Innovations V, Inc.
    Inventors: Steven John Taylor, John Robert Proudfoot, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Afrand Kamali Sarvestani, Leonard Buckbinder, Bernard Lanter, Ferdinand Edward Massari, Koji Yasuda, Spencer Cory Peck, Cheri Snedeker, Diana Le, Jessica Alexander, Anna Liang, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr.
  • ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20220110960
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Inventors: Steven John TAYLOR, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Koji YASUDA, Leonard BUCKBINDER, Bernard LANTER, Spencer Cory PECK, Cheri SNEDEKER, Angela SHE, Jessica ALEXANDER, Anna LIANG, Jenny LIU, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR., Amir H. MOAREFI
  • ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20210283157
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
    Type: Application
    Filed: May 13, 2021
    Publication date: September 16, 2021
    Inventors: Steven John TAYLOR, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Koji YASUDA, Leonard BUCKBINDER, Bernard LANTER, Spencer Cory PECK, Cheri SNEDEKER, Angela SHE, Jessica ALEXANDER, Anna LIANG, Jenny LIU, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR., Amir H. MOAREFI
  • Acylated active agents and methods of their use for the treatment of autoimmune disorders
    Patent number: 11058698
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: July 13, 2021
    Assignee: Flagship Pioneering Innovations V, Inc.
    Inventors: Steven John Taylor, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Koji Yasuda, Leonard Buckbinder, Bernard Lanter, Spencer Cory Peck, Cheri Snedeker, Angela She, Jessica Alexander, Anna Liang, Jenny Liu, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr., Amir H. Moarefi
  • ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE
    Publication number: 20210177877
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Application
    Filed: November 17, 2020
    Publication date: June 17, 2021
    Inventors: Steven John TAYLOR, John Robert PROUDFOOT, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Afrand KAMALI SARVESTANI, Leonard BUCKBINDER, Bernard LANTER, Ferdinand Edward MASSARI, Koji YASUDA, Spencer Cory PECK, Cheri SNEDEKER, Diana LE, Jessica ALEXANDER, Anna LIANG, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR.
  • Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
    Patent number: 10953027
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: March 23, 2021
    Assignee: Flagship Pioneering Innovations V, Inc.
    Inventors: Steven John Taylor, John Robert Proudfoot, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Afrand Kamali Sarvestani, Leonard Buckbinder, Bernard Lanter, Ferdinand Edward Massari, Koji Yasuda, Spencer Cory Peck, Cheri Snedeker, Diana Le, Jessica Alexander, Anna Liang, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr.
  • ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE
    Publication number: 20200197428
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Application
    Filed: February 27, 2020
    Publication date: June 25, 2020
    Inventors: Steven John TAYLOR, John Robert PROUDFOOT, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Afrand KAMALI SARVESTANI, Leonard BUCKBINDER, Bernard LANTER, Ferdinand Edward MASSARI, Koji YASUDA, Spencer Cory PECK, Cheri SNEDEKER, Diana LE, Jessica ALEXANDER, Anna LIANG, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR.
  • ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20200188418
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
    Type: Application
    Filed: February 27, 2020
    Publication date: June 18, 2020
    Inventors: Steven John TAYLOR, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Koji YASUDA, Leonard BUCKBINDER, Bernard LANTER, Spencer Cory PECK, Cheri SNEDEKER, Angela SHE, Jessica ALEXANDER, Anna LIANG, Jenny LIU, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR.